{
    "Trade/Device Name(s)": [
        "Multi-Drug Urine Test Cup",
        "Multi-Drug Urine Test Panel",
        "Wondfo Multi-Drug Urine Test Cup",
        "Wondfo Multi-Drug Urine Test Panel"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K133968",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112071",
        "K121987",
        "K121557",
        "K112236",
        "K112310",
        "K112395",
        "K113624",
        "K130055"
    ],
    "Regulatory Class": "II",
    "Product Code(s)": [
        "DKZ",
        "DIS",
        "JXM",
        "DIO",
        "LAF",
        "LDJ",
        "DJG",
        "LFG",
        "LCM",
        "DJR"
    ],
    "Summary Letter Date": "January 21, 2014",
    "Summary Letter Received Date": "January 27, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolites test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Benzodiazepine test system",
        "Barbiturate test system",
        "Methadone test system",
        "Tricyclic antidepressant drug test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "Cannabinoids",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Phencyclidine",
        "Oxycodone",
        "Buprenorphine",
        "Methadone",
        "Notriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunochromatographic assay",
        "Lateral flow assay"
    ],
    "Methodologies": [
        "Immunochromatographic",
        "Lateral flow",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Multi-Drug Urine Test Cup and Panel for qualitative detection of multiple drugs of abuse using competitive binding lateral flow immunochromatographic assay in urine.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Secobarbital, Oxazepam, Cocaine, Cannabinoids, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Phencyclidine, Oxycodone, Buprenorphine, Methadone, and Notriptyline in human urine at specified cutoff concentrations, for preliminary testing in prescription and over-the-counter settings.",
    "fda_folder": "Toxicology"
}